People

Henrik Zetterberg

Clinical advisory board member of ProMIS Neurosciences. Researcher associated with the University of Gothenburg and University College London, specializing in fluid biomarkers for neurological disorders. Henrik Zetterberg is ALZpath’s Distinguished Scientific Advisor. He researches fluid biomarkers for neurological disease and holds neurochemistry appointments at the University of Gothenburg and University College London. Henrik Zetterberg is listed on the Alzheimer’s Drug Discovery Foundation’s Board of Governors in its Governors group. The foundation lists the outside professional affiliation: Professor of Neurochemistry and Head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg and Clinical Chemist at Sahlgrenska University Hospital. This is a foundation governance or honorary affiliation, not an assertion of operating employment. Henrik Zetterberg is listed by Vesper Bio as Scientific Advisor. Neurochemistry and fluid-biomarker researcher affiliated with Gothenburg/UCL; current Vesper scientific-advisory capacity is source-qualified separately from existing company and foundation affiliations.